Delivery Order SPE2DB24D2106-SPE2DB24FAUTX

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $32,320.49 contract is for the supply of TREMFYA 100 MG/ML INJECTORML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,890.65 order is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialized pharmaceutical product, with a completion date of December 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $19,392.85, is for the provision of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This is a $8,837.99 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TREMFYA 100 MG/ML SYRINGEML medical supplies, with a completion date of May 28, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a $8,266.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4565883614 - TREMFYA 100 MG/ML SYRINGE/ML, with a completion date of September 23, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This federal contract award, valued at $14,876.32, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a firm fixed-price delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products, including...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $39,371.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TREMFYA 100 MG/ML INJECTORML, a specialized pharmaceutical product, with a completion date of February 13, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $20,410.56, is for the delivery of pharmaceutical products to support the medical supply needs of military healthcare facilities. The order includes a variety of prescription drugs, over-the-counter medications, biologics, and medical consumables, such as Xolair, Trikafta, Keytruda, Botox, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,145.71 firm fixed-price delivery order is for the provision of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, and has an ultimate completion date of March 3, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a Firm Fixed Price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,479.47 award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to provide a variety of pharmaceutical products to support military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUTX
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $13,776.05 award is for the supply of TREMFYA 100 MG/ML INJECTOR ML, a biologic medication, to fulfill the recurring pharmaceutical needs of military healthcare facilities.

The award is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's (DoD) global medical requirements. As a prime vendor for the DoD, DMS Pharmaceutical Group supplies both routine and critical medications, including branded and generic drugs, biologics, and consumables, to military health facilities worldwide.

This delivery order does not have a set-aside designation. It is part of DMS Pharmaceutical Group's broader role as a key supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure direct awards for the DLA's Medical Supply Chain division.

Generated 11/21/24, 9:34 AM